{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neuromuscular+Disorder&page=48", "query": { "condition": "Neuromuscular Disorder", "page": 48 }, "page_size": 10 }, "pagination": { "page": 48, "page_size": 10, "total_count": 4097, "total_pages": 410, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neuromuscular+Disorder&page=49&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neuromuscular+Disorder&page=47&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T15:11:09.068Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05218096", "title": "Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Generalized Myasthenia Gravis", "Myasthenia Gravis" ], "interventions": [ { "name": "ALXN2050", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 70, "start_date": "2022-04-27", "completion_date": "2024-04-03", "has_results": true, "last_update_posted_date": "2025-01-09", "last_synced_at": "2026-10-17T15:11:09.068Z", "location_count": 17, "location_summary": "Phoenix, Arizona • Aurora, Colorado • Boca Raton, Florida + 14 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Port Charlotte", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05218096" }, { "nct_id": "NCT03124342", "title": "Vanderbilt ICU Recovery Program Pilot Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Intensive Care Unit Syndrome", "Intensive Care Neurological Disorder", "Intensive Care (ICU) Myopathy", "Intensive Care Psychiatric Disorder (Diagnosis)" ], "interventions": [ { "name": "VANDERBILT ICU RECOVERY PROGRAM", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 232, "start_date": "2017-05-01", "completion_date": "2018-04-30", "has_results": true, "last_update_posted_date": "2019-10-08", "last_synced_at": "2026-10-17T15:11:09.068Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03124342" }, { "nct_id": "NCT00283842", "title": "Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Neuropathies", "Pain" ], "interventions": [ { "name": "DVS SR", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wyeth is now a wholly owned subsidiary of Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 408, "start_date": "2006-03", "completion_date": "2008-06", "has_results": true, "last_update_posted_date": "2011-10-24", "last_synced_at": "2026-10-17T15:11:09.068Z", "location_count": 51, "location_summary": "Mesa, Arizona • Peoria, Arizona • Phoenix, Arizona + 47 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Encino", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00283842" }, { "nct_id": "NCT04402086", "title": "Rheumatology Patient Registry and Biorepository", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatic Diseases", "Adult Onset Still Disease", "Ankylosing Spondylitis", "Psoriatic Arthritis", "Reactive Arthritis", "Antiphospholipid Syndrome", "Systemic Lupus Erythematosus", "Behcet Disease", "Dermatomyositis", "Polymyositis", "Giant Cell Arteritis", "Lyme Disease", "Mixed Connective Tissue Disease", "Polymyalgia Rheumatica", "Rheumatoid Arthritis", "Sarcoidosis", "Systemic Sclerosis", "Scleroderma", "Sjogren's Syndrome", "Undifferentiated Connective Tissue Diseases" ], "interventions": [], "intervention_types": [], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 5000, "start_date": "2020-08-04", "completion_date": "2030-06-01", "has_results": false, "last_update_posted_date": "2026-02-13", "last_synced_at": "2026-10-17T15:11:09.068Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT04402086" }, { "nct_id": "NCT05524883", "title": "Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Duchenne Muscular Dystrophy (DMD)" ], "interventions": [ { "name": "DYNE-251", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dyne Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "16 Years", "sex": "MALE", "summary": "4 Years to 16 Years · Male only" }, "enrollment_count": 86, "start_date": "2022-08-12", "completion_date": "2031-09", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-10-17T15:11:09.068Z", "location_count": 11, "location_summary": "La Jolla, California • Los Angeles, California • Aurora, Colorado + 8 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05524883" }, { "nct_id": "NCT00065702", "title": "Biomarkers of Homeopathy in Fibromyalgia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Fibromyalgia" ], "interventions": [ { "name": "Active liquid remedy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Center for Complementary and Integrative Health (NCCIH)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2000-10", "completion_date": "2002-09", "has_results": false, "last_update_posted_date": "2006-08-18", "last_synced_at": "2026-10-17T15:11:09.068Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00065702" }, { "nct_id": "NCT04559295", "title": "Bone Marrow Concentrate (BMC) Injection in Intervertebral Discs", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Low Back Pain", "Disc Disease", "Disc Degeneration", "Arthropathy Vertebrae", "Sacral Disorder", "Radiculopathy", "Spinal Stenosis" ], "interventions": [ { "name": "Bone Marrow Concentrate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Stem Cures", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 80, "start_date": "2018-11-21", "completion_date": "2021-04-30", "has_results": false, "last_update_posted_date": "2020-09-22", "last_synced_at": "2026-10-17T15:11:09.068Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04559295" }, { "nct_id": "NCT01196442", "title": "Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer-related Problem/Condition", "Neurotoxicity", "Pain", "Peripheral Neuropathy" ], "interventions": [ { "name": "electrical stimulation pain therapy", "type": "OTHER" }, { "name": "questionnaire administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2010-09", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2013-08-23", "last_synced_at": "2026-10-17T15:11:09.068Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01196442" }, { "nct_id": "NCT06384170", "title": "Closed Loop Spinal Cord Stimulation for Neuromodulation of Upper Motor Neuron Lesion Spasticity", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Pain", "Spasticity as Sequela of Stroke", "Upper Motor Neuron Lesion" ], "interventions": [ { "name": "Spinal Cord Stimulation- Closed loop", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2024-12-03", "completion_date": "2026-05", "has_results": false, "last_update_posted_date": "2026-02-06", "last_synced_at": "2026-10-17T15:11:09.068Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06384170" }, { "nct_id": "NCT05514873", "title": "An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Generalized Myasthenia Gravis" ], "interventions": [ { "name": "zilucoplan (RA101495)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB Biopharma SRL", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 26, "start_date": "2022-10-31", "completion_date": "2024-10-23", "has_results": true, "last_update_posted_date": "2025-09-03", "last_synced_at": "2026-10-17T15:11:09.068Z", "location_count": 12, "location_summary": "Scottsdale, Arizona • Los Angeles, California • Rancho Mirage, California + 9 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Rancho Mirage", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "O'Fallon", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05514873" } ] }